Abstract
This cross-sectional study investigates differences by sex in reporting of adverse drug reactions associated with angiotensin-converting enzyme inhibitors combining global and prescription-corrected databases.
| Original language | English |
|---|---|
| Article number | e228224 |
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | JAMA network open |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 20 Apr 2022 |
Bibliographical note
Funding Information:Funding/Support: This work was supported by grant 2020B004 from the Dutch CardioVascular Alliance and European Research Council Consolidator grant 866478.
Keywords
- Angiotensin Receptor Antagonists/adverse effects
- Angiotensin-Converting Enzyme Inhibitors/adverse effects
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Male
- Sex Characteristics